🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 6 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/05/2016 | 51,12 | 51,84 | 51,06 | 51,62 | +0,93% | 1,53% | 8.358.219 |
| 06/05/2016 | 51,36 | 51,50 | 50,63 | 51,15 | -0,91% | 1,69% | 11.031.562 |
| 05/05/2016 | 51,79 | 51,91 | 50,90 | 51,61 | -1,31% | 1,95% | 11.764.010 |
| 04/05/2016 | 52,20 | 52,52 | 51,98 | 52,30 | -0,49% | 1,04% | 8.075.888 |
| 03/05/2016 | 52,61 | 52,91 | 52,34 | 52,56 | -0,40% | 1,09% | 7.966.058 |
| 02/05/2016 | 52,34 | 52,82 | 52,19 | 52,77 | +0,84% | 1,20% | 10.143.487 |
| 29/04/2016 | 53,09 | 53,09 | 52,06 | 52,33 | -1,61% | 1,94% | 13.862.944 |
| 28/04/2016 | 53,33 | 53,65 | 53,01 | 53,19 | -1,01% | 1,22% | 9.531.246 |
| 27/04/2016 | 53,49 | 54,03 | 53,49 | 53,73 | +0,48% | 1,00% | 7.274.587 |
| 26/04/2016 | 53,83 | 53,84 | 53,31 | 53,47 | -0,32% | 0,97% | 7.573.477 |
| 25/04/2016 | 53,89 | 54,05 | 53,44 | 53,65 | -0,92% | 1,13% | 8.677.650 |
| 22/04/2016 | 54,09 | 54,42 | 53,92 | 54,14 | +0,25% | 0,92% | 7.433.988 |
| 21/04/2016 | 53,76 | 54,42 | 53,73 | 54,01 | +0,04% | 1,28% | 11.040.994 |
| 20/04/2016 | 54,53 | 54,77 | 53,86 | 53,99 | -0,49% | 1,68% | 8.929.903 |
| 19/04/2016 | 54,13 | 54,75 | 53,65 | 54,26 | +0,62% | 2,04% | 8.011.122 |
| 18/04/2016 | 53,57 | 54,23 | 53,36 | 53,92 | +0,66% | 1,62% | 8.168.322 |
| 15/04/2016 | 53,94 | 53,96 | 53,32 | 53,57 | -0,55% | 1,19% | 8.839.251 |
| 14/04/2016 | 53,45 | 54,01 | 53,38 | 53,86 | +0,88% | 1,18% | 8.757.822 |
| 13/04/2016 | 52,92 | 53,43 | 52,74 | 53,40 | +1,12% | 1,30% | 8.849.836 |
| 12/04/2016 | 52,45 | 53,20 | 52,42 | 52,81 | +0,53% | 1,47% | 6.221.976 |
| 11/04/2016 | 52,83 | 53,19 | 52,46 | 52,53 | -0,56% | 1,37% | 7.404.749 |
| 08/04/2016 | 53,20 | 53,35 | 52,58 | 52,82 | -0,11% | 1,45% | 7.322.795 |
| 07/04/2016 | 52,81 | 53,23 | 52,53 | 52,88 | -0,38% | 1,32% | 11.042.566 |
| 06/04/2016 | 51,86 | 53,23 | 51,77 | 53,08 | +2,56% | 2,82% | 13.079.459 |
| 05/04/2016 | 51,61 | 52,21 | 51,52 | 51,76 | -0,29% | 1,35% | 9.432.838 |
| 04/04/2016 | 51,44 | 52,13 | 51,29 | 51,91 | +1,30% | 1,63% | 10.741.581 |
| 01/04/2016 | 50,10 | 51,33 | 50,04 | 51,24 | +1,49% | 2,57% | 9.099.889 |
| 31/03/2016 | 50,65 | 51,03 | 50,34 | 50,49 | -0,58% | 1,36% | 8.735.080 |
| 30/03/2016 | 51,03 | 51,10 | 50,68 | 50,78 | -0,19% | 0,82% | 6.711.287 |
| 29/03/2016 | 50,49 | 50,96 | 50,16 | 50,88 | +0,93% | 1,59% | 7.730.782 |